Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies
<b>Background/Objectives</b>: The stress testing of biotherapeutic products is a critical component of drug development, enabling the assessment of stability, biosimilarity, and degradation pathways. Subjecting biosimilar monoclonal antibodies to controlled stress conditions yields essential insight...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2025-04-01
|
| Schriftenreihe: | Pharmaceuticals |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1424-8247/18/4/579 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
